Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Int J Geriatr Psychiatry. 2013 Oct 29;29(5):533–545. doi: 10.1002/gps.4038

Quality of life impacts on 16-year survival of an older ethnically diverse cohort

Barry Gurland 1, Jeanne A Teresi 1, Joseph P Eimicke 2, Mathew S Maurer 3, M Carrington Reid 4
PMCID: PMC4372056  NIHMSID: NIHMS585570  PMID: 24167085

Abstract

Objective

The objective of this study is to examine the prediction of mortality, over 16 years, by the domains and domain elements underlying generic measures of quality of life (QoL).

Methods

The method used was an analysis of mortality in an older (65 + years) representative sample (N = 2130) of a multicultural community in North Manhattan. Five conventional QoL domains were measured by in-home, rater-administered, and computer-assisted questionnaire: depressed mood, pain, self-perceived health, and function and social relationships.

Results

Some domain scales that qualitatively express distress, such as depressed mood and widespread pain, significantly predicted lower mortality (were protective) and felt isolation trended in that direction, whereas domains indicating quantitative limitations such as impairment of functioning in daily tasks, stair climbing, as well as social disengagements and lack of support network significantly predicted higher mortality. Domain elements also mattered; contrary to their domain predictions, increased mortality was predicted by the domain elements of somatic symptoms of depression. Self-perceived poor health reflected the predictive (higher mortality) direction of the limitations cluster.

Conclusions

The internal complexity of QoL is underscored by differential impacts of domains and elements on mortality. Clinical implications include setting distress domains as important clinical goals, whereas strengthening limiting domains could result in lengthening life and secondarily relieving distress. The relative weighting of these goals could be derived from patient preferences and clinical efficacy. Fundamental implications lie in the interaction between the person’s qualitative evaluations of choices and the quantitative building of desired choices for a better QoL.

Keywords: quality of life domains, multicultural older community, 16-year mortality, fundamental and clinical implications

Introduction

Improvement of quality of Life (QoL) is a main goal of “patient centered” clinical and public health interventions (Higginson and Carr, 2001); thus, QoL measures are extensively used in outcomes research, clinical appraisals, and monitoring of service standards. The values assigned to improvements in QoL are influenced also by the duration over which the improvement will be enjoyed (Salomon, 2008); yet, there is incomplete knowledge and inconsistent findings (cited in the discussion) about the extent to which expected years of life are determined by the domains of QoL such as affect, pain, social relationships, self-perceived health, function, and cognitive status, all components of the most widely used QoL generic measures (e.g., Short Form-36, EuroQol, EuroQol Group, 1990; Quality of Well-Being Scale, Kaplan et al., 1997; Ware et al., 2000); or noted in QoL condition-specific measures (e.g., Minnesota Living with Heart Failure Questionnaire, Rector and Cohn, 1992; DEMQOL, Smith et al., 2007).

Such inconsistency might stem from insufficient or varying attention to the various domains and domain elements of QoL and to interactions between them. We consequently expected that the analysis of mortality impacts of QoLs could be clarified by simultaneously including a spectrum of domains and domain elements of QoL as potential predictors and that this strategy might lead to better understanding of the internal structure of QoL and thereby to improved approaches to clinical application. Generating information in this area could serve as a guide to interventions that take account of both quality and longevity implications, thus, for example, strengthening communication between patient and provider about approaches that foster patient-centered care (Naik et al., 2012).

Methods

Sample

This study follows a representative multi-ethnic sample of community-dwelling older persons (N = 2128) for 16 years or to death from any cause, relating domains of QoL as measured at baseline, to length of survival. Data were from the Washington Heights-Inwood Community Aging Project or North Manhattan Aging Project (Gurland et al., 1997; Cheng et al., 2008).

Procedures

Trained raters applied a systematic questionnaire, the Comprehensive Assessment and Referral Evaluation (CARE) (Gurland et al., 1977; Gurland, 1994; Gurland and Katz, 2002) in either English or Spanish, assisted by a computer program.

Measures

Homogeneous scales for the CARE were constructed by latent class and factor analysis (Golden et al., 1984b; Teresi et al., 1989). Thus, each scale has distinct content and relationships within a pool of items developed by a multidisciplinary team versed in the prevailing medical, psychiatric, psychological and social service professional. and lay language of discomforts and functioning as it pertains to older populations in the community and in health an care settings. Consequently, the scales are recognizable as potential needs for relieving interventions and as impediments to improving QoL; in the absence of such needs or impediments, certain items reflect positive QoL. Further, psychometric evidence of validity has been published for constructs (Teresi et al., 1984a), concurrent and predictive validity (Teresi et al., 1984b), case detection (Golden et al., 1983), and identification of item bias across ethnicity (Teresi et al., 1995). Mortality data were from the National Death Index (Division of Vital Statistics, National Center for Health Statistics). Measures (Table 1) assessed the following domains: depressed mood and related somatic complaints, happiness, pain, self-perceived health, function (basic and instrumental activities of daily living (ADL), climbing stairs, range of movement, restriction of desired activities), social relationships (felt isolation, disengagement, support), cognitive impairment, subjective memory, and cardiovascular syndrome.

Table 1.

Description of measures in the analysis

Domain Number of items Description/example of items
Affect
 Depressed mood 22 Regrets; sadness most of day, everyday, or more than 2 weeks; not worth living, and nothing enjoyed
 Related somatic items   5 Poor appetite, disrupted sleep, lack of energy, and loss of weight
 Happiness   1 Four levels: very happy, fairly happy, not very happy, and not happy at all
Pain
 Physical pain 13 Admits to “arthritis or rheumatism,” “painful stiffness or swelling of joints,” “painful stiffness or swelling of muscles or tendons,” “pain in legs or feet,” “painful swelling in arms or hands,” “backaches or neck aches,” “headaches,” “frequent other aches or pains not localized,” “frequent other aches or pains in specific parts,” and “pain stops ordinary activities”
 Widespread pain   3 Joints, muscles, and head
 Severe pain   3 Frequent medication use; pain disrupts sleep and activities
 Site-specific pain   5 Chest pain on exertion and pain limits walking
 Self-perceived health   1 Age peer comparison: four levels: excellent, good, fair, and poor
Function
 Basic and instrumental activities of daily living 15 Level of assistance with meal preparation, shopping, financial matters, bathing/showering, heavy chores, dressing, etc.
 Stairs   3 Effort to climb stairs without resting
Constructed range of movement   3 Unable to touch toes, lift arms over head, and reach behind back
Health restricts desired activities 19 Health problems limit leisure activities, light chores, heavy chores, mobility, etc.
Social Relationships
 Felt isolation   6 Lonely, not close, no confidante, and keeps problems to self
 Disengagement 13 No hobbies, excursions, exercise, television, volunteering, games, clubs, religious activities
 Social support 14 Marital status, household membership, and family contacts
Cognitive impairment (memory)
 Subjective   9 Complaints about lapses and interference with tasks, e.g., chores, shopping, and business
 Cognitive test 15 An objective test of cognitive performance
Cardiovascular syndrome 10 Mentions symptoms of heart trouble, high blood pressure, chest pain-discomfort on slight exertion, relieved by rest-medication, continuous-heavy-gripping-central, difficulty-or assistance walking due to pain in chest, prescribed medicine for heart condition or hypertension
 Demographics Age, gender, race/ethnicity, education and income

Aims

The main aim of the analyses was to determine the impact by QoL domains on survival over a period of 16 years. Selected scales represent each QoL domain. Published findings guided the selection of scales; details and citations are placed in the Discussion section. Two basic models were tested. The first model contains scales and continuous variables, with some exceptions. The second model substitutes variables that were already included in scales but are of substantial interest and have been examined in previous studies, for example, happiness, satisfaction, restricted health limitations, subjective memory, and affective and somatic depression items. Variables have been ordered by QoL domains.

Analyses

The analytic approach for mortality prediction was a Cox proportional hazards model. As an initial check of colinearity among potential predictors, a forward stepwise Cox regression model was performed. Redundant variables were dropped from the subsequent models. Examination of these results provided guidance in selecting variables for the final model. Additional tests of colinearity were performed by examining the tolerance and variance inflation factors. The proportional hazards assumption was checked by including interaction terms of the main effect by log transformed time in the model, and also graphically, including Schoenfeld residuals; several variables found to be in violation were removed. Sensitivity analyses examined the influence of variables that were dropped. Estimates and results were similar among final models and those tested in sensitivity analyses.

Results

Socio-demographic characteristics

Table 2 provides information regarding participants’ baseline demographic, clinical, and functional status. Participants had a mean age of 76 years, were mostly women (69.3%), and a high proportion were Latino (46.8%). A relatively large proportion (23.5%) reported that pain caused them to stop ordinary activities. The mean depression score for the sample at baseline was 5.31 (0–22, standard deviation (SD) = 4.17): 20% of the sample scored 5+ on the depression scale, accounting for 80% of those taking medications for emotions; 6.8% reported being sad or depressed most of every day for at a least 2 weeks in the past month. By the 16-year endpoint, there were 1507 deaths (70.8% of cohort). The average age of death was 81.45 years (SD = 8.22); the time to death was on average 10.22 years (SD = 5.60). The baseline distribution of demographics and candidate predictors of death is shown in Table 2.

Table 2.

Baseline (n = 2128) distribution of demographics and candidate predictors of death

n %
Demographics
 Female    1475      69.3
 Self-reported race
  Latino      996      46.8
  African American      717      33.7
  White      415      19.5
 Age at baseline (mean, SD)        75.99       (5.82)
 Education (years) (mean, SD)          8.24       (4.59)
 Average annual income of household (mean, SD)+ 10,513.3 (7752.39)
Affect
 Depression homogeneous scale (mean, SD)          5.31       (4.17)
Pain
 Physical pain (mean, SD)          4.18       (3.13)
 Pain stops ordinary activity—Yes      500      23.5
Self-perceived health
 Self perceived health (versus age peers)
  Excellent      478      22.5
  Good      930      43.7
  Fair      590      27.7
  Poor      130        6.1
Function
 Function reported by subject (mean, SD)          2.79       (3.57)
 Unable to touch toes, lift arms over head, reach behind back (mean, SD)          0.37       (0.84)
Social relationships
 Felt isolation (mean, SD)          1.00       (1.23)
 Social disengagement (mean, SD)          6.76       (2.57)
Memory
 Care Diagnostic (mean, SD)          2.73       (2.97)
Cardiovascular syndrome
 Cardiovascular (mean, SD)          2.01       (2.08)

SD, standard deviation.

Table 3 shows the results from the Cox regression analyses. For those variables that were coded in the impaired or disordered direction, the impact is portrayed either in terms of shorter survival by significant and larger hazard ratios (HRs) or in the direction of longer survival (protective effects) indicated by HRs below one. For example, an HR of 1.20 translates to an average risk of death 20% higher for those with a limitation than for those without it. Most variables were coded so that higher scores indicated more impairment.

Table 3.

Results of Cox proportional hazards models (+ indicates that variables are in the less impairment or higher levels direction)

Model 1
Model 2
95% CI for HR
95% CI for HR
B SE Sig. HR Lower Upper B SE Sig. HR Lower Upper
Depression
 Depression homogeneous scale (higher score = more severe)(depress1) −0.023 0.009 0.009 0.978 0.961 0.994
 Happiness (happy_1s) (scored in the unhappy direction) −0.014 0.062 0.817 0.986 0.873 1.114
 Affective items (g7_1xr) (higher score, more affective disorder) −0.060 0.024 0.012 0.942 0.899 0.987
 Related somatic items (somatic1) (higher score, reflects greater symptoms) −0.013 0.031 0.680 0.987 0.928 1.050
Pain
 Physical pain (high score reflects greater impairment)(pain_1) −0.039 0.010 <0.001 0.961 0.942 0.981
 Pain stops ordinary activities (0 = no; 1 = yes)(s159s) −0.387 0.080 <0.001 0.679 0.580 0.794
 Often takes medication to relieve pain (0 = no;1 = yes)(s160s) 0.065 0.074 0.381 1.067 0.923 1.232
Self health
 Self perceived health (age peer comparison)(slfhlth1s) 0.096 0.035 0.007 1.101 1.027 1.180
  Excellent (versus poor)+ −0.365 0.128 0.004 0.694 0.540 0.893
  Good (versus poor)+ −0.235 0.114 0.039 0.791 0.633 0.989
  Fair (versus poor)+ −0.262 0.111 0.018 0.770 0.620 0.956
Function
 Function reported by subject (high score = greater impairment)(sfctpr1) 0.077 0.011 <0.001 1.080 1.057 1.103
 Unable to touch toes, lift arms over head, reach behind back (high score = greater impairment)(romp) 0.111 0.035 <0.001 1.118 1.044 1.197
 Activity change to reduce risk (0 = not = limited; 1 limited)(s199s) −0.099 0.062 0.111 0.906 0.802 1.023
 Observed cannot lift both arms over head at same time (0 = no; 1 = yes)(s209) 0.605 0.085 <0.001 1.832 1.550 2.165
 Health restrictions (restrctrv) 0.050 0.009 <0.001 1.051 1.033 1.071
 Effort to climb stairs (rest after one or two flights versus other)(s194r)
  Must rest after one or two flights of stairs 0.293 0.067 <0.001 1.341 1.176 1.528
  Cannot climb even one flight of stairs without resting 0.286 0.089 0.001 1.330 1.117 1.585
Social
 Felt isolation (high score reflects greater felt isolation)(isolate_1) −0.012 0.025 0.632 0.988 0.941 1.038
 Social disengagement (high score reflects greater disengagement)(engage_1) 0.052 0.013 <0.001 1.054 1.028 1.080
 Social support (high score reflects greater social support)(supprt_1)+ −0.035 0.012 0.003 0.966 0.944 0.988
Cognitive impairment
 Care diagnostic (high score reflects greater impairment)(cdiagpr1) 0.020 0.011 0.073 1.020 0.998 1.042
 Subjective memory (high score reflects greater impairment)(memry_1s) 0.004 0.013 0.754 1.004 0.978 1.031
Cardiovascular (high score = more symptoms)(cardiov1) 0.058 0.013 <0.001 1.059 1.032 1.087 0.040 0.013 0.002 1.041 1.014 1.068
Demographics
 Age at T1 (age_1) 0.073 0.005 <0.001 1.076 1.066 1.087 0.084 0.005 <0.001 1.088 1.077 1.098
 Gender (male = 0; female = 1)(gender) 0.497 0.060 <0.001 0.608 0.541 0.684 0.544 0.060 <0.001 0.580 0.516 0.652
 Self-reported race (selfrace)
  Latino −0.362 0.085 <0.001 0.696 0.590 0.822 −0.292 0.084 0.001 0.747 0.633 0.881
  African American 0.013 0.076 0.866 1.013 0.873 1.175 0.077 0.075 0.306 1.080 0.932 1.252
 Yearly income (income_y) + 0.000 0.000 0.009 1.000 1.000 1.000 0.000 0.000 0.006 1.000 1.000 1.000
 Education (years)(educorgl) + 0.019 0.007 0.008 1.019 1.005 1.034 0.014 0.007 0.054 1.014 1.000 1.028

SE, standard error; HR, hazard ratio, CI, confidence interval; B, Beta; Sig, Significance level.

Affect

As shown in Table 3, Model 1, the depression scale was significantly predictive (p = 0.009) but acted protectively (HR = 0.978), whereas Model 2 shows that the somatic-free scale of depressed affect was comparably significant and protective. In contrast, the scale of somatic symptoms associated with depression was not significant. Sensitivity analyses unadjusted for other variables showed that the somatic scale was predictive of mortality (p = 0.008; HR = 1.077), whereas depressed affect was not significant (p = 0.121; HR = 0. 968). Further, in Table 4, when demographic, cardiovascular, pain, and felt isolation scales were added to the Cox regression, the somatic scale became marginally significant in the direction of increased mortality (p = 0.079; HR = 1.055), but the affective scale remained not significant with the direction of effects being protective (p = 0.391; HR = 0.980). The effect of then adding self-reported function, self-perceived health, and disengagement was that the somatic scale lost significance (p = 0.851), and the affective scale gained significance in the direction of protective impact (p = 0.009;HR = 0.941). Moreover, examination of zero-order correlations between individual items in the depression scale and mortality at 16 years showed that only one out of 19 pure affective items increased mortality (p < 0.05), whereas the comparable figure for the somatic scale was four out of 8.

Table 4.

Cox regression focusing on somatic-free affective (g7_1xr), and Related affective-free somatic (somatic1) scales

95% CI for HR
95% CI for HR
B SE Sig. HR Lower Upper B SE Sig. HR Lower Upper
Affective items (g7_1xr) −0.020 0.023 0.391 0.980 0.936 1.026 −0.061 0.024 0.009 0.941 0.898 0.985
Related somatic items (somatic1) 0.054 0.031 0.079 1.055 0.994 1.120 −0.006 0.031 0.851 0.994 0.936 1.056
Age at T1 (age_1) 0.091 0.005 <0.001 1.095 1.085 1.105 0.076 0.005 <0.001 1.079 1.069 1.089
Gender (male = 0; female = 1) (gender) −0.410 0.059 <0.001 0.664 0.592 0.745 −0.463 0.059 <0.001 0.629 0.560 0.707
Self-reported race (selfrace)
 Latino −0.322 0.084 <0.001 0.725 0.615 0.855 0.356 0.085 <0.001 0.700 0.593 0.827
 African American 0.119 0.075 0.113 1.126 0.972 1.305 0.050 0.075 0.506 1.051 0.907 1.219
Yearly income (income_y)+ 0.000 0.000 <0.001 1.000 1.000 1.000 0.000 0.000 0.013 1.000 1.000 1.000
Education (years) (educorgl)+ 0.007 0.007 0.285 1.007 0.994 1.021 0.017 0.007 0.017 1.017 1.003 1.031
Cardiovascular (high score reflects greater cardiovascular problems) (cardiov1) 0.074 0.013 <0.001 1.077 1.050 1.105 0.055 0.013 <0.001 1.056 1.029 1.083
Physical pain (high score reflects greater impairment) (pain_1) −0.008 0.010 0.451 0.993 0.973 1.012 −0.044 0.010 <0.001 0.957 0.938 0.976
Felt isolation (high score reflects greater isolation) (isolate_1) −0.006 0.024 0.796 0.994 0.949 1.041 −0.002 0.024 0.921 0.998 0.952 1.045
Self perceived health (age peer comparison) (slfhlth1s) 0.091 0.035 0.010 1.095 1.021 1.173
Function reported by subject (high score reflects greater impairment) (sfctpr1) 0.100 0.009 <0.001 1.105 1.086 1.124
Social disengagement (high score reflects greater disengagement) (engage_1) 0.055 0.013 <0.001 1.057 1.031 1.083

SE, standard error; HR, hazard ratio, CI, confidence interval; B, Beta; Sig, Significance level.

Because the findings of protective effects of the depression scale impact on mortality might seem counter-intuitive, we examined the selected zero-order correlations of depression with other variables posited or found in the literature to be related to depression. All were related to depression in the expected direction (p < 0.001): unhappiness (0.208), life dissatisfaction (0.368), gender (0.175), function (0.317), self-perceived health (0.403), energy (0.562), disengagement (0.252), and pain (0.478), whereas the somatic scale was appropriately correlated with severity of self-reported health (0.330).

Pain

Self-reported baseline pain was significantly (p < 0.001) protective (HR = 0.961) and, if severe enough to stop ordinary activity (Table 3, Model 2), was equally significant and strongly protective (HR = 0.679) (Table 3). However, often taking medications to relieve pain was not significant.

Self-perceived health

Worse self-perceived health, as a continuous variable, was a significant (p = 0.007) predictor of mortality (HR = 1.101) (Table 3, Model 2) while excellent as contrasted with poor self-perceived health was strongly protective (p = 0.004; HR = 0.694): that is, the adjusted risk of death was 31% lower.

Function

There was a significant (p < 0.001) increased risk of mortality associated with self-report of functional impairment (HR = 1.080), and by the objective testing of range of arm movement (HR = 1.118) treated continuously; however, the HR for the single item, “cannot lift both arms over head at the same time,” was 1.832. Additionally, the item, “must rest after one or two flights of stairs,” was predictive of mortality (HR = 1.341). The health restrictions subscale, which measures health limitations on desired levels of activities, was also significant (p < 0.001; HR = 1.051).

Social relationships

Felt isolation was not a significant predictor of mortality, but social disengagement was predictive of mortality (p < 0.001, HR = 1.054), and social support was protective (p = 0.003, HR = 0.966).

Cognitive impairment

Cognitive impairment was not significant nor was subjective memory.

Cardiovascular

The syndrome of cardiovascular symptoms was a significant predictor of mortality (p < 0.001, HR = 1.029).

Socio-demographics

As expected, several demographic variables were highly salient (p < 0.001) predictors of mortality: older age (HR = 1.076), female status (HR = 0.608), and self-identified Latino status (HR = 0.696). The adjusted average risk of death for women was 39% lower than for men and 30% lower for Latinos than for non-Latino whites. Education and annual household income had negligible but significant (p = 0.009) impact on survival.

Time to death

To determine the constancy of shorter and longer term effects, we compared the results over 6 years with that over 16 years: most estimates were consistent; exceptions were significant over 16 years but not over 6 years.

Discussion

Data gathered by the 400 items in the CARE interview questionnaire on health, social, and functional problems of this representative multicultural sample of over 2000 ethnically diverse community residing elders, are a rich source of information for examining the structure and meaning of QoL. We had access to over 20 psychometrically derived scales with content related to QoL and to numerous domain elements. We opted for a domain level of analysis, not focusing on a global indicator of QoL.

Main findings

The predictive power for 16-year mortality varied among the domains, with distressing–comforting domains (depressed mood, pain, felt isolation, and loneliness), mostly qualitative and nonobservable latent attributes, being weaker predictors of mortality than the limiting-enabling, more quantitative and observable domains (functional capacities, self-reported health, engagement in social activities and tasks, and social support network). These distinctions could parallel distinctive physician or patient preferences for the goals of treatment, bearing on relief of distress or overcoming limitations that influence longevity; a balancing of clinical emphases that threads through all of medicine. The patient’s preferences can be brought out by exploring the values they attach to each of the dimensions. Moreover, each of the domains carries its own need for services.

Depression, somatics, and mortality

The analyses of depression and mortality covered prediction by the full scale of depression, a somatic-free affective scale, an affective-free somatic scale, and distinctive items in the depression scale. Control variables included the other generic QoL domains, cardiac symptoms, and demographic indicators in various combinations. Across this dissection of relationships, the depression and affective scales and items tended to afford a protective influence on mortality, whereas the somatic items and scales predicted increased mortality. This latter mortality effect was nullified when conditioned by scales of functioning. Although the protective direction of the impact on mortality by depression seemed counterintuitive, a check on the directionality of correlations between depression and multiple other scales were all as conventionally expected.

Several research reports have questioned whether depression, as a scale score or as a diagnosis, substantially impacts cardiac mortality (Lane et al., 2001; Sorensen et al., 2005; and Frasure-Smith and Lesperance, 2008). However, Kurdyak et al. (2011), followed a cohort of hospitalized cardiac patients in which the controlled HR for mortality in severe versus minimal depression was 1.35. Parashar et al. (2006) found adjusted HRs for increased mortality rates of 1.34–1.71 (p = 0.05) at 6 months after myocardial infarction (MI) in 1873 patients. Carney et al. (2008) found that the HR for all-cause mortality associated with major or minor depression was 1.76 for 5-year survival after MI, and Lett et al. (2004), in a review of morbidity and mortality of coronary artery disease, noted that adjusted risk for depression was between 1.5 and 2.5.

Our analysis showed that it is only the somatic component of depression that predicts mortality, perhaps accounting for some of the conflict between published studies. Recent reports by other investigators are along the same lines. Martens et al. (2010) confirmed in a sample of 473 patients with MI, the earlier conclusion of De Jonge et al. (2006), and of Schiffer et al. (2009), that somatic, not cognitive, symptoms of depression are associated with a worse cardiovascular prognosis, possibly by effects on heart rate variability (De Jonge et al., 2006). Smith and Torrance (2012) followed 380 consecutive patients with congestive heart failure for a median of 2.3 years: somatic symptoms of depression (HR = 1.41, 95% confidence interval (CI):1.05–1.88, p = 0.02) were independently associated with increased mortality risk, not explained by exertion fatigue; they recommended that behavioral interventions should focus on somatic manifestations of depression in patients with congestive heart failure.

These findings support the notion that it is the somatic items within most depression measures that may be the driving force in predictions of mortality. Furthermore, our review of measures of depression in common use, as well as Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition criteria for major depression episode, highlighted the admixture of somatic items. For example, 17% of the Beck Depression Inventory Short Form (Beck et al., 1961) items are somatic; 43% of the Hamilton Rating Scale (Hamilton, 1960), 13% of the Geriatric Depression Scale (Yesavage et al., 1983), 44% of the Short Form-36 depression subsection (Ware and Sherbourne, 1992), 56% of the Patient Health Questionnaire 9 (Spitzer et al., 1999), 40% (4/10) of the Montgomery Asberg Depression Rating Scale (Montgomery and Asberg, 1979), and one fourth (3/12) of the EURO-D (Prince et al., 1999) items are also somatic. About one fourth of the CARE Depression Scale (Methods section) was comprised of somatic items. The Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition major depression episode specifies somatic states in 5/9 criteria, as well as the requirement to judge and exclude possible somatic causes.

If, as we find, depression is associated with a reduced mortality risk, it would call for a theory of causal pathways: one such candidate, “depressive realism,” first described by Alloy and Abramson (1979) and Dobson and Franche (1989), remains controversial (Moore and Fresco, 2007). This theory argues that depression, within limits of severity, makes a person more accurate in perception of problems, progress, and need for help. Alternatively, depressive complaints may call clinical attention to the need for instituting or adapting treatment, or it may exaggerate the baseline level of illness symptoms.

Pain

As with depression, inconsistencies in findings on pain and mortality have been noted (Torrance et al., 2010), possibly due to differences between samples (Reilly et al., 1990). Several studies have found, as have we, no excess mortality associated with painful syndromes. Andrews et al. (2013) found that after adjustment, especially for function, pain did not predict death over 10 years in a nationally representative sample (N = 12,631) of community subjects 60 years and older. Macfarlane et al. (2007) replicated the design of his own earlier studies (Macfarlane et al., 2001) on mortality of chronic widespread pain, but, although his previous studies had shown a doubling of cancer and cardiovascular mortality, the replication study (Mini-Finland Health Survey, N = 7182 persons aged 30 years and over, followed for over 14 years) found no increase of mortality and noted a protective effect of pain for several disease-specific causes of death including cancer death (relative risk: 0.64; 95% CI: 0.46–0.91). Torrance et al. (2010) also reported a protective effect of chronic pain on death from cerebrovascular disease, in a postal survey of 3605 randomly selected members of the general population aged over 25 years, and 6940 recruited subjects receiving repeat prescriptions of analgesics; but severe chronic pain (in angina, arthritis, backache, injury, and cancer) was significantly associated with all-cause and cardiac mortality over 10 years. This underlines, as in the case of depression, the added information obtainable from distinctions within the boundaries of QoL. However, because coexisting depression symptoms were controlled in the analysis of pain impacts, the realism theory cannot readily be carried over to pain. Nevertheless, it may be that readiness to report pain could act to focus and intensify treatment.

Function

There is general agreement with our finding that functional impairment significantly increases mortality. A meta-analysis of 80 studies on the association between varieties of physical activity and mortality, estimated correlations of 0.65 for total activity, 0.74 for leisure activity, 0.64 for ADL and 0.83 for occupational activities (Samitz et al., 2011). Hutchings et al. (2011) screened over 4000 papers bearing upon QoL outcomes of femoral fracture: function (ADL) scales were the most commonly used predictors. Our scale relies on self-report, but is cross-validated by observational testing of the range of arm movements: this test procedure, manageable over a range of health problems was predictive of mortality, and one item, “inability to lift arms over head,” (n = 203; 9.5% of sample) conferred an 83% higher risk of death: a clinically meaningful mortality impact.

Cognitive impairment

The test of cognitive impairment is one (imperfect) manifestation of dementia, but there are other potential associations of dementia, such as limitations of function, and there are variables that can reflect underlying vulnerability to dementia, such as advanced age or cardiovascular symptoms. Thus, variables that can reflect the causes and consequences of dementia may predict mortality in part because they are associated with dementia and at the same time compete for predicting dementia consequences (like mortality) with cognitive impairment as a more direct indicator of dementia. Thus, in this study, cognitive impairment standing alone does predict 16-year mortality (HR = 1.117, p < 0.001) but is not significantly predictive when accompanied by the other scales, especially function (Sensitivity analyses available on request).

Self-perceived health

The four-level item was a significant predictor of mortality, and the risk of death for those reporting excellent health was 31% lower than for those reporting poor health, after adjusting for several scales of functioning. Other studies have also found that self-assessed health has substantial predictive power for survival even after controlling for objective health indicators (Dowd and Zajacova, 2007; Huisman et al., 2007; Erdogan-Ciftci et al., 2010). The pathways accounting for the impact on 16-year survival of self-perceived health is suggested by two related analyses: (i) the influence of self-perceived health on mortality at 16 years without adjustment for other variables is 1.219, whereas the addition of other variables as in the model in this paper reduces the HR to 1.101 and (ii) linear regression analyses show that the major influences on self-perceived health are health restrictions (standardized beta = 0.248 (p < 0.001)), depression (beta = 0.156 (p < 0.001)), pain (beta = 0.120 (p < 0.001)), disengagement (beta = 0.106 (p < 0.001)), cognitive impairment (beta = 0.064, (p = 0.007)), cardiovascular (beta = 0.049 (p = 0.018)) and gender (beta = −0.042 (p = 0.046)) (Tables available on request).

Social relations

Mortality, adjusted for other covariates, was predicted by the baseline lack of social support and disengagement scales but not by the felt isolation scale: this is in keeping with the impact on death rates by quantitatively limiting relationships, in contrast to qualitatively distressing states. Aside from the one item on loneliness that is confounded by the contingency of physical limitation, none of the other five loneliness items significantly predicted mortality. Other researchers have noted an association between low social support and mortality. In the Reduction of Atherothrombosis for Continued Health Registry (N = 44,573), living alone (19%) increased the four-year risk of cardiovascular mortality for age 66–80 years (adjusted HR, 1.12 (95% CI: 1.01–1.26)), but not for older persons older than age 80 years (Udell et al., 2012). In a registry (PREMIER) of patients hospitalized with Acute MI in 2003 through 2004, living alone did not, with multivariable adjustment, alter 4-year mortality (Bucholz et al., 2011). Bucholz and Krumholz (2012) discuss several studies connecting living alone to mortality risk, possibly through poor nutrition, noncompliance, and inactivity; this did not apply to loneliness. However, Perissinotto et al. (2012) found in a nationally representative sample of older persons that loneliness (feeling left out, isolated, or lacking companionship) as distinct from social support and depression, increased mortality over 6 years (adjusted HR, 1.45 at 95% CI: 1.11–1.88).

Intervention to resolve causal direction

Ambiguities in the direction of influence among health disorders (Gurland et al., 2000) are well known, including issues of reverse causality, confounding coexistent influences, and serial timing of cohort data. Reverse causality might work to increase levels of depression, for example in cardiac disorders, through increased cytokine levels, health restrictions and lack of exercise (Barbour et al., 2007). For these reasons, hypotheses based on statistical associations must be put to the test of intervention. However, an extensive literature review on treating depression in cardiac disorders (Thombs et al., 2008) reported only “modest” reductions in depressive symptoms and no change in cardiac outcomes, whereas the Enhancing Recovery in Coronary Heart Disease Patients trial achieved no impact on survival by cognitive behavioral therapy and antidepressants (Berkman et al., 2003; van Melle et al., 2004).

Limitations of the study

Community sample

Neither medical nor psychiatric diagnoses were included in the analyses, although items in the scale of depressed mood correspond to almost all the criteria for major depressive episode or dysthymia, an objective test of cognitive status was highly related to the diagnosis of dementia, and a cardiovascular scale of ischemia and dyspnea is highly suggestive of cardiac insufficiency. Similarly, the diagnoses underlying pain were not obtained, but the symptom syndrome referenced primarily widespread joint and muscle involvement and also some constellations that classically point to cardiac ischemia. The level of the subject’s functioning is based mainly on self-report but correlates strongly with the objective test of range of upper limb movement. We did not concentrate on acute events, yet, 17.8% of subjects had been hospitalized in the previous year, 5.7% had spent 2 weeks or more ill in bed, 23.8% reported having a heart condition, and 15.5% had chest pain on exertion (relieved by rest or medication in 7.5%). Validity: the scope of the research validity of the CARE scales rests in part upon psychometric analyses described under Methods section, and in part upon the derivation of its content. The latter was developed by a multidisciplinary research team, including clinicians, for international studies on the health and social problems of older persons in the community and in long-term care settings (Gurland et al., 1983). Thus, the domains reflect expert interests couched in the lay language of patients and corresponding to the domains of “generic” and some condition-specific QoL measures. However, there may be no direct way of relating the current findings to those of QoL measures that build on the views of patients or their care givers about their QoL or quality of care, nor to global indices of quality. For analyses of the determinants of QoL and implications for related interventions, multiple domains offer greater transparency in relevance to specific interventions than do global indicators, even when the latter are preference weights applied to domain scores as the raw material. Effect sizes: the size of the effect on mortality is shared among 14 competing variables that have an HR of p ≤ 0.05 in the Cox model, thus limiting the effect size of each particular variable. However, in practice, an intervention to improve any single variable can be expected to have a larger impact than is reflected in the “shared” HR. Similarly, intervening with several of the significant variables is likely to increase the desired impact on mortality to a greater degree than would be implied by summating their respective HRs.

Conclusions

The internal complexity of QoL is underscored by the differential impacts of domains and domain elements on mortality. Clinical implications include setting distress domains as important therapeutic goals while strengthening limiting domains that could lengthen life and secondarily relieve distress. The relative weighting of these goals could be derived from patient preferences and clinical efficacy. Fundamental challenges to research lie in describing, understanding, and influencing the interaction between the person’s qualitative evaluations of choices and the quantitative building of desired choices for a better QoL (Gurland and Gurland, 2009a, 2009b).

Key points.

  • The internal complexity of quality of life is underscored by the differential mortality impacts of its domains and domain elements.

  • Patient preferences can weight clinical balancing of relief of distressing (or comforting) domains with the strengthening of the longevity promoting limiting (or enabling) domains.

  • Insufficient control of the differing mortality impacts of elements within domains may account for some inconsistencies in published studies.

  • Expressed degrees of comforting (or distressing) domains may identify desired elements of the choice environment, which the enabling (or limiting) domains build into a living context.

Acknowledgments

Dr. Richard Mayeux, professor and Chair of the Columbia University Neurological Institute, has led the multidisciplinary, population-based investigation of Alzheimer’s disease and related conditions known as the Washington Heights-Inwood Community Aging Project or North Manhattan Aging Project (NMAP) NIA # 2M01RR000645-25A1.

Footnotes

Conflict of interest

None declared.

References

  1. Alloy LB, Abramson LY. Judgment of contingency in depressed and nondepressed students: sadder but wiser? J Exp Psychol Gen. 1979;108(4):441–485. doi: 10.1037//0096-3445.108.4.441. [DOI] [PubMed] [Google Scholar]
  2. Andrews JS, Stijacic Cenzer I, Yelin E, Covinsky KE. Pain as a Risk Factor for Disability or Death. JAGS. 2013;61:583–589. doi: 10.1111/jgs.12172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbour KA, Edenfield TM, Blumenthal JA. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. J Cardiopulm Rehabil Prev. 2007;27:359–367. doi: 10.1097/01.HCR.0000300262.69645.95. [DOI] [PubMed] [Google Scholar]
  4. Beck AT, Ward C, Mendelson M. Beck Depression Inventory (BDI) Arch Gen Psychiatry. 1961;4(6):561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  5. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–3116. doi: 10.1001/jama.289.23.3106. [DOI] [PubMed] [Google Scholar]
  6. Bucholz EM, Krumholz HM. Loneliness and Living Alone Comment: on “Loneliness in Older Persons” and “Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis”. Arch Intern Med. 2012;172(14):1084–1085. doi: 10.1001/archinternmed.2012.2649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bucholz EM, Rathore SS, Gosch K, et al. Coronary artery disease: Effect of Living Alone on Patient Outcomes After Hospitalization for Acute Myocardial Infarction. The Am J Cardiol. 2011;108(7):943–948. doi: 10.1016/j.amjcard.2011.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carney RM, Freedland KE, Steinmeyer B, et al. Depression and five year survival following acute myocardial infarction: A prospective study. J Affect Disord. 2008;109:133–138. doi: 10.1016/j.jad.2007.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheng H, Gurland BJ, Maurer MS. Self-Reported Lack of Energy (Anergia) Among Elders in a Multiethnic Community. J Gerontol. 2008;63A(7):707–714. doi: 10.1093/gerona/63.7.707. [DOI] [PubMed] [Google Scholar]
  10. Dobson K, Franche RL. A conceptual and empirical review of the depressive realism hypothesis. Canadian J of Behavioral Science. 1989;21:419–433. [Google Scholar]
  11. Dowd, Zajacova Does the predictive power of self-rated health for subsequent mortality risk vary by socioeconomic status in the US? Int J Epidemiol. 2007;36(6):1214–1221. doi: 10.1093/ije/dym214. [DOI] [PubMed] [Google Scholar]
  12. Erdogan-Ciftci E, van Doorslaera E, Bago d’Uvaa T, van Lentheb F. Do self-perceived health changes predict longevity? Soc Sci Med. 2010;71(11):1981–1988. doi: 10.1016/j.socscimed.2010.09.003. [DOI] [PubMed] [Google Scholar]
  13. EuroQol Group. EuroQol—a new facility for the measurement of health related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9. [DOI] [PubMed] [Google Scholar]
  14. Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62–71. doi: 10.1001/archgenpsychiatry.2007.4. [DOI] [PubMed] [Google Scholar]
  15. Golden RR, Teresi JA, Gurland BJ. Detection of dementia and depression cases with the Comprehensive Assessment Referral Evaluation interview schedule. Int J Aging Hum Dev. 1983;16:242–254. doi: 10.2190/by6j-960y-ehn7-6lbc. [DOI] [PubMed] [Google Scholar]
  16. Golden RR, Teresi JA, Gurland BJ. Development of indicator scales for the Comprehensive Assessment and Referral Evaluation (CARE) interview schedule. J Gerontol. 1984b;39(2):138–46. doi: 10.1093/geronj/39.2.138. [DOI] [PubMed] [Google Scholar]
  17. Gurland BJ. Comprehensive Interviews: The Comprehensive Assessment and Referral Evaluation (CARE) In: Copeland JRM, Abou-Saleh MT, Blazer DG, editors. Principles and Practice of Geriatric Psychiatry. John Wiley & Sons Ltd; London: 1994. pp. 250–251. Chap. 35. [Google Scholar]
  18. Gurland B, Copeland J, Kelleher M, Kuriansky J, Sharpe L, Dean L. The Mind and Mood of Aging: The Mental Health Problems of the Community Elderly in New York and London. Haworth; New York: 1983. [Google Scholar]
  19. Gurland BJ, Gurland RV. The Choices, Choosing Model of Quality of Life: Description and Rationale. Int J Geriatr Psychiatry. 2009a;24:90–95. doi: 10.1002/gps.2110. [DOI] [PubMed] [Google Scholar]
  20. Gurland BJ, Gurland RV. The Choices, Choosing Model of Quality of Life: Linkages to a Science Base. Int J Geriatr Psychiatry. 2009b;24:84–89. doi: 10.1002/gps.2109. [DOI] [PubMed] [Google Scholar]
  21. Gurland B, Katz S. Comprehensive Interviews: The Comprehensive Assessment and Referral Evaluation (CARE): An Approach to evaluating potential for achieving quality of life. In: Copeland JRM, About-Saleh MT, Blazer DG, editors. Principles and Practice of Geriatric Psychiatry. Second. John Wiley & Sons; New York: 2002. pp. 174–176. [Google Scholar]
  22. Gurland B, Kuriansky J, Sharpe L, et al. The comprehensive assessment and referral evaluation (CARE)—Rationale, development and reliability. Int J Aging Hum Dev. 1977;8(1):9–14. doi: 10.2190/cl3j-0e20-97xx-mv5l. [DOI] [PubMed] [Google Scholar]
  23. Gurland BJ, Katz S, Chen J. Index of affective suffering: Linking a classification of depressed mood to impairment in quality of life. Am J Geriatr Psychiatr. 1997;5(3):192–210. doi: 10.1097/00019442-199700530-00003. [DOI] [PubMed] [Google Scholar]
  24. Gurland B, Katz S, Pine ZM. Complex Unity and Tolerable Uncertainty: Relationships of Physical Disorder and Depression. In: Williamson GM, Shaffer DR, Parmalee PA, editors. Physical illness and depression in older adults: A handbook of theory, research, and practice. Kluwer Academic/Plenum Publishers; New York: 2000. pp. 311–330. [Google Scholar]
  25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Higginson IJ, Carr AJ. Using quality of life measures in the clinical setting. BMJ. 2001;322:1297. doi: 10.1136/bmj.322.7297.1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Huisman M, van Lenthe F, Mackenbach J. Does the predictive power of self-rated health for subsequent mortality risk vary by socioeconomic status in the US? Int J Epidemiol. 2007;36:1214–1221. doi: 10.1093/ije/dym214. [DOI] [PubMed] [Google Scholar]
  28. Hutchings L, Fox R, Chesser T. Proximal femoral fractures in the elderly: how are we measuring outcome? [Review] Injury. 2011;42(11):1205–1213. doi: 10.1016/j.injury.2010.12.016. [DOI] [PubMed] [Google Scholar]
  29. de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry. 2006;163:138–144. doi: 10.1176/appi.ajp.163.1.138. [DOI] [PubMed] [Google Scholar]
  30. Kaplan RM, Sieber WJ, Ganiats TG. The Quality of Well-Being Scale a comparison etc. Psychol Health. 1997;12:783–791. [Google Scholar]
  31. Kurdyak PA, Chong A, Gnam WH, Goering P, Alter DA. Depression and self-reported functional status: Impact on mortality following acute myocardial infarction. J Eval Clin Pract. 2011;17:444–445. doi: 10.1111/j.1365-2753.2010.01446.x. [DOI] [PubMed] [Google Scholar]
  32. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: Effects of depression and anxiety. Psychosom Med. 2001;63:221–230. doi: 10.1097/00006842-200103000-00005. [DOI] [PubMed] [Google Scholar]
  33. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med. 2004;66:305–315. doi: 10.1097/01.psy.0000126207.43307.c0. [DOI] [PubMed] [Google Scholar]
  34. Macfarlane GJ, McBeth J, Silman AJ. Widespread body pain and mortality: Prospective population-based study. Brit Med J. 2001;323:1–5. doi: 10.1136/bmj.323.7314.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Macfarlane GJ, Jones GT, Knekt P, et al. Is the report of widespread body pain associated with long-term increased mortality? Data from the Mini-Finland Health Survey. Rheumatology. 2007;46:805–807. doi: 10.1093/rheumatology/kel403. [DOI] [PubMed] [Google Scholar]
  36. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med. 2010;40(5):807–814. doi: 10.1017/S0033291709990997. [DOI] [PubMed] [Google Scholar]
  37. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom Med. 2004;66:814–822. doi: 10.1097/01.psy.0000146294.82810.9c. [DOI] [PubMed] [Google Scholar]
  38. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389. doi: 10.1192/bjp.134.4.382. [DOI] [PubMed] [Google Scholar]
  39. Moore MT, Fresco DM. Depressive Realism and Attributional Style: Implications for individuals at risk for depression. Behavior Therapy. 2007;38:144–154. doi: 10.1016/j.beth.2006.06.003. [DOI] [PubMed] [Google Scholar]
  40. Naik N, Hess R, Unruh M. Measurement of Health-Related Quality of Life in the Care of Patients with ESRD: Isn’t This the Metric That Matters? Semin Dial. 2012;25(4):439–444. doi: 10.1111/j.1525-139X.2012.01110.x. [DOI] [PubMed] [Google Scholar]
  41. Parashar S, Rumsfeld JS, Spertus JA, et al. Time course of depression and outcome of myocardial infarction. Arch Intern Med. 2006;166:2035–2043. doi: 10.1001/archinte.166.18.2035. [DOI] [PubMed] [Google Scholar]
  42. Perissinotto CM, Cenzer IS, Covinsky KE. Loneliness in Older Persons: A Predictor of Functional Decline and Death. Arch Intern Med. 2012;172(14):1078–1084. doi: 10.1001/archinternmed.2012.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Prince MJ, Reischies F, Beekman AT, et al. Development of the EURO-D scale—a European, Union initiative to compare symptoms of depression in 14 European centres. BJP. 1999;174:330–338. doi: 10.1192/bjp.174.4.330. [DOI] [PubMed] [Google Scholar]
  44. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017e25. doi: 10.1016/0002-8703(92)90986-6. [DOI] [PubMed] [Google Scholar]
  45. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: A 25 year prospective study of 100 patients. Ann Rheum Dis. 1990;49:363–369. doi: 10.1136/ard.49.6.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Salomon JA. Quality Adjusted Life Years. Measurement and modeling: quality-adjusted life years. In: Heggenhougen K, Quah S, editors. International Encyclopedia of Public Health. Vol. 5. Academic Press; San Diego: 2008. pp. 449–454. [Google Scholar]
  47. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose–response meta-analysis of cohort studies. Int J Epidemiol. 2011;40:1382–1400. doi: 10.1093/ije/dyr112. [DOI] [PubMed] [Google Scholar]
  48. Schiffer AA, Pelle AJ, Smith OR, et al. Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. J Clin Psychiatr. 2009;70(12):1667–1673. doi: 10.4088/JCP.08m04609. [DOI] [PubMed] [Google Scholar]
  49. Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. [Review] Curr Pain Headache Rep. 2012;16(3):191–198. doi: 10.1007/s11916-012-0256-0. [DOI] [PubMed] [Google Scholar]
  50. Smith SC, Lamping DL, Banerjee S, et al. The development of a new measure of health related quality of life for people with dementia: DEMQOL. Psychologic Med. 2007;37:737–746. doi: 10.1017/S0033291706009469. [DOI] [PubMed] [Google Scholar]
  51. Sorensen FC, Friis-Hasche E, Haghfelt T, Bech P. Postmyocardial infarction mortality in relation to depression: A systematic critical review. Psychotherapeuticaet Psychosomatica. 2005;74:69–80. doi: 10.1159/000083165. [DOI] [PubMed] [Google Scholar]
  52. Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA. 1999;282:1737–1744. doi: 10.1001/jama.282.18.1737. [DOI] [PubMed] [Google Scholar]
  53. Teresi JA, Golden RR, Gurland BJ. Concurrent and predictive validity of indicator scales developed for the Comprehensive Assessment and Referral Evaluation interview schedule. J Gerontol. 1984a;39(2):158–165. doi: 10.1093/geronj/39.2.158. [DOI] [PubMed] [Google Scholar]
  54. Teresi J, Golden R, Gurland B, Wilder D, Bennett R. Construct validity of indicator-scales developed for the Comprehensive Assessment and Referral Evaluation interview schedule. J Gerontol. 1984b;39(2):147–157. doi: 10.1093/geronj/39.2.147. [DOI] [PubMed] [Google Scholar]
  55. Teresi JA, Cross PS, Golden RR. Some applications of latent trait analysis to the measurement of ADL. J Gerontol Soc Sci. 1989;44(5):S196–204. doi: 10.1093/geronj/44.5.s196. [DOI] [PubMed] [Google Scholar]
  56. Teresi JA, Golden RR, Cross P, et al. Item bias in cognitive screening measures: Comparisons of elderly White, Afro-American, Hispanic and high and low education subgroups. J Clin Epidemiol. 1995;48(4):473–483. doi: 10.1016/0895-4356(94)00159-n. [DOI] [PubMed] [Google Scholar]
  57. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: A systematic review. JAMA. 2008;300(18):2161–2171. doi: 10.1001/jama.2008.667. [DOI] [PubMed] [Google Scholar]
  58. Torrance N, Elliott AM, Lee AJ, Smith BH. Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain. 2010;14:380–386. doi: 10.1016/j.ejpain.2009.07.006. [DOI] [PubMed] [Google Scholar]
  59. Udell JA, Steg PG, Scirica BM, et al. Living Alone and Cardiovascular Risk in Outpatients at Risk of or with Atherothrombosis the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Arch Intern Med. 2012;172(14):1086–1095. doi: 10.1001/archinternmed.2012.2782. [DOI] [PubMed] [Google Scholar]
  60. Ware JE, Sherbourne CD. The MOS 36 item short-form health survey (SF–36): 1. Conceptual framework and item selection. Med Care. 1992;30:473–80. [PubMed] [Google Scholar]
  61. Ware JE, Jr, Kosinski M, Dewey JE. How to score, version 2 of the SF–36 Health Survey (Standard & Acute Forms) Quality Metric Incorporated; Lincoln, RI: 2000. [Google Scholar]
  62. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression rating scale a preliminary report. J Psychiatr Res. 1983;17:27. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]

RESOURCES